Cost-effectiveness of CI in developing countries

被引:14
|
作者
Magro, Isabelle [1 ]
Emmett, Susan D. [2 ]
Saunders, James [3 ]
机构
[1] Geisel Sch Med Dartmouth, Hanover, NH USA
[2] Duke Univ, Sch Med, Duke Global Hlth Inst, Div Head & Neck Surg & Commun Sci, Durham, NC USA
[3] Geisel Sch Med Dartmouth, Dartmouth Hitchcock Med Ctr, Div Otolaryngol, Lebanon, NH 03756 USA
关键词
cochlear implants; cost-effectiveness; developing countries; disability adjusted life years; HEARING-IMPAIRED CHILDREN; ADJUSTED LIFE YEAR; QUALITY-OF-LIFE; COCHLEAR IMPLANTATION; UTILITY ANALYSIS; UNITED-KINGDOM; DEAF EDUCATION; ACHIEVEMENTS; PERFORMANCE;
D O I
10.1097/MOO.0000000000000451
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose of review Cost-effectiveness of cochlear implants is a major concern for expanding these services to low-income and middle-income developing countries. Recent findings Recent studies have applied appropriate methodology to make determination of cost-effectiveness for cochlear implants in developing countries. In addition, important parameters that effect cost-effectiveness have been reviewed in a systematic way. The combination of these new studies along with existing reports of cochlear implant programmes in developing countries allows for a discussion of cost and outcomes determinants that drive cost-effectiveness in these environments. Summary Cochlear implants are a very cost-effective treatment for profound hearing loss in all high-resource countries and in many low-income and middle-income developing countries. A number of cost considerations affect cost-effectiveness of cochlear implants in developing countries including device cost and device-related expenses such as power consumption and reliability, but also including rehabilitation and access-related expenses. Large-scale programmes confer an advantage for cost-effectiveness, primarily through device-related savings.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF TRAINING IN DEVELOPING-COUNTRIES
    BAS, D
    [J]. INTERNATIONAL LABOUR REVIEW, 1988, 127 (03) : 355 - 369
  • [2] Cost-effectiveness in the diagnosis of tuberculosis: choices in developing countries
    Molicotti, Paola
    Bua, Alessandra
    Zanetti, Stefania
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (01): : 24 - 38
  • [3] The Use of Cost-Effectiveness Analysis for Pediatric Immunization in Developing Countries
    Gauvreau, Cindy Low
    Ungar, Wendy J.
    Koehler, Jillian Clare
    Zlotkin, Stanley
    [J]. MILBANK QUARTERLY, 2012, 90 (04): : 762 - 790
  • [4] Cost-effectiveness of radiology: Economic and diagnostic considerations in developing countries
    Elmeligy, MR
    [J]. ACADEMIC RADIOLOGY, 1996, 3 : S125 - S125
  • [5] Cost-effectiveness analysis of education and health interventions in developing countries
    McEwan, Patrick J.
    [J]. JOURNAL OF DEVELOPMENT EFFECTIVENESS, 2012, 4 (02) : 189 - 213
  • [6] Rotavirus Vaccination: Cost-Effectiveness and Impact on Child Mortality in Developing Countries
    Atherly, Deborah
    Dreibelbis, Robert
    Parashar, Umesh D.
    Levin, Carol
    Wecker, John
    Rheingans, Richard D.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 : S28 - S38
  • [7] Cost-effectiveness of cervical-cancer screening in five developing countries
    Goldie, SJ
    Gaffikin, L
    Goldhaber-Fiebert, JD
    Gordillo-Tobar, A
    Levin, C
    Mahé, C
    Wright, TC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20): : 2158 - 2168
  • [8] The value of hygiene promotion: cost-effectiveness analysis of interventions in developing countries
    Sijbesma, Christine
    Christoffers, Trea
    [J]. HEALTH POLICY AND PLANNING, 2009, 24 (06) : 418 - 427
  • [9] Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
    Valencia-Mendoza, Atanacio
    Bertozzi, Stefano M.
    Gutierrez, Juan-Pablo
    Itzler, Robbin
    [J]. BMC INFECTIOUS DISEASES, 2008, 8 (1)
  • [10] Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
    Atanacio Valencia-Mendoza
    Stefano M Bertozzi
    Juan-Pablo Gutierrez
    Robbin Itzler
    [J]. BMC Infectious Diseases, 8